KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $8.2 million.

  • Neogenomics' Other Non-Current Assets rose 4670.37% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 4670.37%. This contributed to the annual value of $5.9 million for FY2024, which is 2412.48% up from last year.
  • Per Neogenomics' latest filing, its Other Non-Current Assets stood at $8.2 million for Q3 2025, which was up 4670.37% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Other Non-Current Assets peaked at $11.1 million during Q1 2021, and registered a low of $4.1 million during Q2 2024.
  • For the 5-year period, Neogenomics' Other Non-Current Assets averaged around $6.3 million, with its median value being $6.0 million (2025).
  • Per our database at Business Quant, Neogenomics' Other Non-Current Assets crashed by 7870.11% in 2021 and then skyrocketed by 7489.57% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Other Non-Current Assets stood at $7.2 million in 2021, then fell by 28.72% to $5.1 million in 2022, then dropped by 7.18% to $4.7 million in 2023, then rose by 24.12% to $5.9 million in 2024, then skyrocketed by 39.13% to $8.2 million in 2025.
  • Its Other Non-Current Assets stands at $8.2 million for Q3 2025, versus $7.1 million for Q2 2025 and $6.0 million for Q1 2025.